Biophotonics refers to the combination of field of photonics and biology. It is a light-based technology used in medicine and life-science for generation, detection of photons, manipulation, and quantum units of lights. This technology is also used in the study of the biological tissue, molecules, and cells. It is also used in imaging and therapeutic techniques in widespread clinical use.
Based on application, market is segmented into see through imaging, inside imaging, spectro molecular, surface imaging, microscopy, light therapy, biosensors, and other analytic sensing. Furthermore, based on end use, biophotonics market is segmented into medical diagnostics, medical therapeutics, test components, and non-medical applications.
Market Dynamics
Based on end use, medical diagnostics accounted for the largest revenue share in the global biophotonics market, followed by medical therapeutics and test components. Among region, North America held dominant position in the global biophotonics market, followed by Europe and Middle East & Africa.
Key features of the study:
- This report provides in-depth analysis of the global Biophotonics market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022–2030), considering 2021 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global Biophotonics market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Becton, Dickinson & Co., Affymetrix Inc., Carl Zeiss, Olympus America, Andor Technology, and Hamamatsu Photonics
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global Biophotonics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global Biophotonics market
Detailed Segmentation:
- Global Biophotonics Market, By End Use:
- Medical Diagnostics
- Medical Therapeutics
- Test Components
- Non-Medical Applications
- Global Biophotonics Market, By Application:
- See Through Imaging
- Inside Imaging
- Spectro Molecular
- Surface Imaging
- Microscopy
- Light Therapy
- Biosensors
- Other Analytic Sensing
- Global Biophotonics Market, By Region:
- North America
- Latin America
- By Country
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- By Country
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- By Country
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- By Country
- GCC
- Israel
- Rest of Middle East
- Africa
- By Region/Country
- South Africa
- Central Africa
- North Africa
- Company Profiles
- Becton, Dickinson & Co.*
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performanc
- Market Strategies
- Dickinson & Co.
- Affymetrix Inc
- Carl Zeiss
- Olympus America
- Andor Technology
- Hamamatsu Photonics
“*” marked represents similar segmentation in other categories in the respective section.
